1. Ott, Gudrun, Havemeyer, Antje, Clement, Bernd. 2014. The mammalian molybdenum enzymes of mARC. In Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry, 20, 265-75. doi:10.1007/s00775-014-1216-4. https://pubmed.ncbi.nlm.nih.gov/25425164/
2. Rixen, Sophia, Havemeyer, Antje, Tyl-Bielicka, Anita, Mikula, Michal, Clement, Bernd. 2019. Mitochondrial amidoxime-reducing component 2 (MARC2) has a significant role in N-reductive activity and energy metabolism. In The Journal of biological chemistry, 294, 17593-17602. doi:10.1074/jbc.RA119.007606. https://pubmed.ncbi.nlm.nih.gov/31554661/
3. Wu, Dehai, Wang, Yan, Yang, Guangchao, Wang, Jiabei, Liu, Lianxin. 2020. A novel mitochondrial amidoxime reducing component 2 is a favorable indicator of cancer and suppresses the progression of hepatocellular carcinoma by regulating the expression of p27. In Oncogene, 39, 6099-6112. doi:10.1038/s41388-020-01417-6. https://pubmed.ncbi.nlm.nih.gov/32811980/
4. Plitzko, Birte, Havemeyer, Antje, Kunze, Thomas, Clement, Bernd. 2015. The pivotal role of the mitochondrial amidoxime reducing component 2 in protecting human cells against apoptotic effects of the base analog N6-hydroxylaminopurine. In The Journal of biological chemistry, 290, 10126-35. doi:10.1074/jbc.M115.640052. https://pubmed.ncbi.nlm.nih.gov/25713076/